Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).

导出 OA

翻译打印收藏纠错

作者： Erika K S M,Leenders ^[1] ; Harm,Westdorp ^[2] ; Roger J,Brüggemann ^[3] ; Jan,Loeffen ^[4] ; Christian,Kratz ^[5] ; John,Burn ^[6] ; Nicoline,Hoogerbrugge ^[7] ; Marjolijn C J,Jongmans ^[8]

作者单位： Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands. ^[1] Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. ^[2] Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. ^[3] Department of Pharmacy, Radboud University Nijmegen Medical Centre, Radboud Institute for Health Sciences, Nijmegen, The Netherlands. ^[4] Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands. ^[5] Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. ^[6] Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. ^[7] Institute of Genetic Medicine Newcastle University, Newcastle upon Tyne, UK. ^[8] Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands. marjolijn.jongmans@radboudumc.nl. ^[9] Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. marjolijn.jongmans@radboudumc.nl. ^[10] Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. marjolijn.jongmans@radboudumc.nl. ^[11]